Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Entropy Neurodynamics Limited (formerly known as Tryptamine Therapeutics Limited) ABN/ARBN ...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Entropy Neurodynamics Limited on 6ix
In the deck
Earlier from Entropy Neurodynamics
- Entropy Advances TRP-8803 to US Phase 2 in Depression
- Application for quotation of securities - ENP
- Trading Halt
- TRP 8803 manufacturing secured for Phase 2/3 advancement
- Change of Director's Interest Notice - HJ
Later from Entropy Neurodynamics
- Investor Webinar Presentation
- Appendix 4E and 2026 Annual Report
- All Patients Improve, 50% Achieve 12-Week BED Remission
- Notification of Date of 2026 AGM
- Notification regarding unquoted securities - ENP
Follow Entropy Neurodynamics into a list and get an email when it puts out news.
Follow Entropy Neurodynamics